Skip to main content

JPMORGAN CHASE & CO (JPM-PM) Stock Forecast 2025 - AI Price Prediction & Analysis


JPMORGAN CHASE & CO (JPM-PM) AI Stock Price Forecast & Investment Analysis

JPMORGAN CHASE & CO Stock Price Chart and Technical Analysis

Loading JPMORGAN CHASE & CO interactive price chart and technical analysis...

JPMORGAN CHASE & CO (JPM-PM) - Comprehensive Stock Analysis & Investment Research

Deep dive into JPMORGAN CHASE & CO's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about JPMORGAN CHASE & CO, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For JPMORGAN CHASE & CO: JPMORGAN CHASE & CO operates in the Finance sector, positioning it as a large-cap market leader.

JPMORGAN CHASE & CO (Stock Symbol: JPM-PM) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

.

The company has established itself as a major market leader with significant institutional backing.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing JPMORGAN CHASE & CO's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For JPMORGAN CHASE & CO: With $174426M in annual revenue, the company demonstrates developing profitability.

Annual Revenue: $174426 million .

Market Capitalization: $50453 million - Classified as a large-cap stock with institutional-grade stability.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for JPMORGAN CHASE & CO stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For JPMORGAN CHASE & CO: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for JPMORGAN CHASE & CO stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: JPMORGAN CHASE & CO's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For JPMORGAN CHASE & CO: Market positioning analysis based on available financial and operational metrics.

JPMORGAN CHASE & CO strategically competes in the highly dynamic National Commercial Banks marketplace, positioning itself as a dominant large-cap market leader with significant competitive moats and institutional investor confidence .

JPMORGAN CHASE & CO (JPM-PM) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for JPMORGAN CHASE & CO stock analysis.

Loading JPMORGAN CHASE & CO comprehensive fundamental analysis and insider trading data...

Deep dive into JPMORGAN CHASE & CO's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if JPMORGAN CHASE & CO stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For JPMORGAN CHASE & CO: With a P/E ratio of 0.95, the market sees the stock as potentially undervalued.

P/E Ratio 0.95x
P/B Ratio 0.14x
Market Cap $50453M
Dividend Yield 27.72%
EPS $19.53
Book Value/Share $128.93
Revenue/Share $62.10
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently JPMORGAN CHASE & CO converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For JPMORGAN CHASE & CO:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess JPMORGAN CHASE & CO's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For JPMORGAN CHASE & CO:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal JPMORGAN CHASE & CO's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For JPMORGAN CHASE & CO:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively JPMORGAN CHASE & CO uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For JPMORGAN CHASE & CO:

Understanding Financial Statement Data

What these metrics mean: Key figures from JPMORGAN CHASE & CO's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For JPMORGAN CHASE & CO: With annual revenue of $174426M, JPMORGAN CHASE & CO operates at significant scale.

Income Statement ($ Millions)
Total Revenue $174426M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Dividends Per Share $5.30
Payout Ratio 0.3%
Shares Outstanding 2795M

Latest JPMORGAN CHASE & CO Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting JPMORGAN CHASE & CO (JPM-PM) stock price and investment outlook.

, source: Financial Times

JPMorgan Chase boss Jamie Dimon gave the go-ahead for a new 3mn square-foot tower in London after a top adviser to Sir Keir Starmer flew to New York to offer assurances about the government’s business ...

JPMORGAN CHASE & CO Competitors & Peer Analysis - Finance Sector

Comparative analysis of JPMORGAN CHASE & CO against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $552M 14.2x 1.0x
AMJB Unlock Forecast - 30 Days FREE Trial $85170M 1.4x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $791M 200.7x 0.8x
AROW Unlock Forecast - 30 Days FREE Trial $504M 15.0x 1.2x
ASRV Unlock Forecast - 30 Days FREE Trial $51M 13.5x 0.5x
ATLO Unlock Forecast - 30 Days FREE Trial $191M 13.6x 1.0x
BAC Unlock Forecast - 30 Days FREE Trial $388386M 13.9x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $183162M 6.8x 0.6x
BAC-PE Unlock Forecast - 30 Days FREE Trial $144903M 5.7x 0.5x
BAC-PK Unlock Forecast - 30 Days FREE Trial $180450M 6.6x 0.6x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9119193M 336.6x 30.0x
BAC-PM Unlock Forecast - 30 Days FREE Trial $162347M 6.1x 0.5x
BAC-PN Unlock Forecast - 30 Days FREE Trial $150840M 5.7x 0.5x
BAC-PO Unlock Forecast - 30 Days FREE Trial $130977M 4.9x 0.4x
BAC-PP Unlock Forecast - 30 Days FREE Trial $123171M 4.6x 0.4x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $126726M 4.8x 0.4x
BAC-PS Unlock Forecast - 30 Days FREE Trial $142117M 5.4x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1599646M 57.8x 5.3x
BANC Unlock Forecast - 30 Days FREE Trial $2780M 16.9x 0.8x
BANC-PF Unlock Forecast - 30 Days FREE Trial $3725M 24.7x 1.1x
BANF Unlock Forecast - 30 Days FREE Trial $3720M 16.1x 2.1x
BANFP Unlock Forecast - 30 Days FREE Trial $873M 3.7x 0.5x
BCAL Unlock Forecast - 30 Days FREE Trial $629M 38.9x 1.1x
BFC Unlock Forecast - 30 Days FREE Trial $1233M 18.7x 2.0x
BHRB Unlock Forecast - 30 Days FREE Trial $976M 8.9x 1.2x
BML-PG Unlock Forecast - 30 Days FREE Trial $143950M 5.4x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $140871M 5.4x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $143144M 5.6x 0.5x
BML-PL Unlock Forecast - 30 Days FREE Trial $139845M 5.4x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $8747M 15.3x 1.5x
C Unlock Forecast - 30 Days FREE Trial $193910M 13.0x 0.9x
CAC Unlock Forecast - 30 Days FREE Trial $686M 13.0x 1.0x
CARE Unlock Forecast - 30 Days FREE Trial $411M 13.3x 1.0x
CASH Unlock Forecast - 30 Days FREE Trial $1681M 26.1x 2.0x
CBKM Unlock Forecast - 30 Days FREE Trial $74M x 0.9x
CBNA Unlock Forecast - 30 Days FREE Trial $203M 14.7x 1.2x
CBNK Unlock Forecast - 30 Days FREE Trial $467M 11.4x 1.2x
CBU Unlock Forecast - 30 Days FREE Trial $3029M 15.6x 1.6x
CFBK Unlock Forecast - 30 Days FREE Trial $151M 8.4x 0.8x
CFNB Unlock Forecast - 30 Days FREE Trial $236M 46.5x 1.2x
CFR Unlock Forecast - 30 Days FREE Trial $8010M 13.2x 1.8x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1159M 1.9x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1771M 14.6x 2.2x
CMA Unlock Forecast - 30 Days FREE Trial $10496M 14.3x 1.3x
CMTV Unlock Forecast - 30 Days FREE Trial $136M 17.9x 1.2x
COF Unlock Forecast - 30 Days FREE Trial $138253M 16.5x 1.2x
COF-PI Unlock Forecast - 30 Days FREE Trial $12003M x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $11526M x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $11062M x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $10439M x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $10394M x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $56839M 4.2x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1255M 27.7x 0.9x
DCOMG Unlock Forecast - 30 Days FREE Trial $1144M 26.1x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $833M 18.9x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $125M 6.5x 0.8x
FCF Unlock Forecast - 30 Days FREE Trial $1706M 12.9x 1.1x
FDBC Unlock Forecast - 30 Days FREE Trial $257M 10.9x 1.1x
FFBC Unlock Forecast - 30 Days FREE Trial $2398M 9.8x 0.9x
FHN Unlock Forecast - 30 Days FREE Trial $11474M 12.8x 1.3x
FHN-PC Unlock Forecast - 30 Days FREE Trial $13027M 15.4x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $12643M 15.2x 1.4x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9364M 11.2x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2640M x 4.3x
FISI Unlock Forecast - 30 Days FREE Trial $621M 8.1x 1.0x
FMCB Unlock Forecast - 30 Days FREE Trial $757M 8.2x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $6036M 11.9x 0.9x
FNLC Unlock Forecast - 30 Days FREE Trial $290M 9.6x 1.1x
FRME Unlock Forecast - 30 Days FREE Trial $2124M 9.5x 0.9x
FRMEP Unlock Forecast - 30 Days FREE Trial $1489M 6.7x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $945M 12.7x 0.8x
FULT Unlock Forecast - 30 Days FREE Trial $3353M 10.2x 1.0x
FULTP Unlock Forecast - 30 Days FREE Trial $3549M 11.2x 1.0x
FUNC Unlock Forecast - 30 Days FREE Trial $240M 10.2x 1.2x
GNTY Unlock Forecast - 30 Days FREE Trial $553M 15.3x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $836M 12.5x 1.1x
HBAN Unlock Forecast - 30 Days FREE Trial $23744M 11.1x 1.1x
HBANL Unlock Forecast - 30 Days FREE Trial $37390M 17.5x 1.7x
HBANM Unlock Forecast - 30 Days FREE Trial $32763M 16.0x 1.5x
HBANP Unlock Forecast - 30 Days FREE Trial $24985M 12.7x 1.1x
HOPE Unlock Forecast - 30 Days FREE Trial $1373M 33.0x 0.6x
HWBK Unlock Forecast - 30 Days FREE Trial $228M 10.2x 1.4x
JPM Unlock Forecast - 30 Days FREE Trial $859915M 14.9x 2.4x
JPM-PC Unlock Forecast - 30 Days FREE Trial $70215M 1.3x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $69835M 1.3x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $56072M 1.1x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $53696M 1.0x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $54534M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $50453M 1.0x 0.1x
KEY Unlock Forecast - 30 Days FREE Trial $20394M 112.5x 1.0x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27765M 157.7x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $23764M 139.9x 1.2x
KEY-PK Unlock Forecast - 30 Days FREE Trial $23420M 139.7x 1.2x
KEY-PL Unlock Forecast - 30 Days FREE Trial $27953M 157.7x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $164661M 9321.4x 1057.4x
LCNB Unlock Forecast - 30 Days FREE Trial $227M 9.8x 0.8x
MER-PK Unlock Forecast - 30 Days FREE Trial $187780M 6.9x 0.6x
MFG Unlock Forecast - 30 Days FREE Trial $17940M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $174M 9.5x 0.9x
MZHOF Unlock Forecast - 30 Days FREE Trial $84511M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1425M 11.9x 1.0x
NBTB Unlock Forecast - 30 Days FREE Trial $2111M 15.0x 1.1x
NEWT Unlock Forecast - 30 Days FREE Trial $303M 5.5x 0.8x
NEWTG Unlock Forecast - 30 Days FREE Trial $729M 12.3x 1.9x
NEWTH Unlock Forecast - 30 Days FREE Trial $718M 12.2x 1.9x
NEWTI Unlock Forecast - 30 Days FREE Trial $728M 12.5x 1.9x
NEWTZ Unlock Forecast - 30 Days FREE Trial $722M 12.2x 1.9x
NIC Unlock Forecast - 30 Days FREE Trial $1883M 13.7x 1.6x
NKSH Unlock Forecast - 30 Days FREE Trial $193M 16.5x 1.1x
NWBI Unlock Forecast - 30 Days FREE Trial $1759M 11.2x 1.0x
OCFC Unlock Forecast - 30 Days FREE Trial $1083M 12.3x 0.7x
ONB Unlock Forecast - 30 Days FREE Trial $8519M 14.2x 1.0x
ONBPO Unlock Forecast - 30 Days FREE Trial $9816M 17.4x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9761M 17.3x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $49M 3.2x 0.4x
PFIS Unlock Forecast - 30 Days FREE Trial $495M 14.3x 1.0x
PNFP Unlock Forecast - 30 Days FREE Trial $7129M 11.5x 1.0x
PNFPP Unlock Forecast - 30 Days FREE Trial $1925M 3.3x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2511M 15.5x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $22956M 10.7x 1.2x
RF-PC Unlock Forecast - 30 Days FREE Trial $21188M 10.7x 1.1x
RF-PE Unlock Forecast - 30 Days FREE Trial $15569M 8.0x 0.8x
RF-PF Unlock Forecast - 30 Days FREE Trial $23019M 11.1x 1.2x
SFNC Unlock Forecast - 30 Days FREE Trial $2696M 14.1x 0.8x
SFST Unlock Forecast - 30 Days FREE Trial $417M 16.1x 1.2x
SHBI Unlock Forecast - 30 Days FREE Trial $591M 9.8x 1.0x
SMBK Unlock Forecast - 30 Days FREE Trial $623M 14.5x 1.2x
SNNF Unlock Forecast - 30 Days FREE Trial $18M x 0.7x
SNV Unlock Forecast - 30 Days FREE Trial $6706M 8.1x 1.2x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3522M 4.5x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3624M 4.8x 0.6x
STEL Unlock Forecast - 30 Days FREE Trial $1623M 15.0x 1.0x
TBBK Unlock Forecast - 30 Days FREE Trial $2857M 15.5x 3.7x
TRMK Unlock Forecast - 30 Days FREE Trial $2350M 10.8x 1.1x
UBFO Unlock Forecast - 30 Days FREE Trial $175M 14.2x 1.3x
UBOH Unlock Forecast - 30 Days FREE Trial $106M 10.1x 1.3x
UMBF Unlock Forecast - 30 Days FREE Trial $8508M 16.2x 1.1x
UMBFO Unlock Forecast - 30 Days FREE Trial $2017M 3.8x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $76313M 10.8x 1.2x
USB-PA Unlock Forecast - 30 Days FREE Trial $1215178M 183.6x 19.2x
USB-PH Unlock Forecast - 30 Days FREE Trial $28111M 4.3x 0.4x
USB-PP Unlock Forecast - 30 Days FREE Trial $35202M 5.4x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $23619M 3.6x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $25240M 3.8x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $28499M 4.4x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $211M 12.1x 1.2x
VLY Unlock Forecast - 30 Days FREE Trial $6400M 13.6x 0.8x
VLYPN Unlock Forecast - 30 Days FREE Trial $14464M 32.1x 1.9x
VLYPO Unlock Forecast - 30 Days FREE Trial $14126M 31.1x 1.8x
VLYPP Unlock Forecast - 30 Days FREE Trial $14244M 31.3x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $73804M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1215M 9.8x 1.3x
WAFD Unlock Forecast - 30 Days FREE Trial $2523M 10.3x 0.8x
WAFDP Unlock Forecast - 30 Days FREE Trial $1292M 5.8x 0.4x
WBHC Unlock Forecast - 30 Days FREE Trial $2123M 33.3x 3.8x
WBS Unlock Forecast - 30 Days FREE Trial $9793M 11.0x 1.0x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3201M 4.0x 0.3x
WBS-PG Unlock Forecast - 30 Days FREE Trial $3982M 4.8x 0.4x
WFC Unlock Forecast - 30 Days FREE Trial $269420M 13.2x 1.5x
WFCNP Unlock Forecast - 30 Days FREE Trial $4723M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $60585M 3.1x 0.3x
WFC-PC Unlock Forecast - 30 Days FREE Trial $56176M 2.9x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $54382M 2.8x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $3872202M 195.1x 21.4x
WFC-PY Unlock Forecast - 30 Days FREE Trial $76298M 3.9x 0.4x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $61120M 3.1x 0.3x
WSBC Unlock Forecast - 30 Days FREE Trial $3115M 22.2x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2400M 18.0x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $3225M 11.5x 1.2x
ZION Unlock Forecast - 30 Days FREE Trial $7863M 8.2x 1.2x
ZIONP Unlock Forecast - 30 Days FREE Trial $3000M 3.8x 0.4x

Frequently Asked Questions - JPMORGAN CHASE & CO Stock Forecast

How accurate are JPMORGAN CHASE & CO stock predictions?

Our AI model shows a 48% Spearman correlation coefficient for JPM-PM predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence JPMORGAN CHASE & CO stock price forecasts?

Our analysis considers JPMORGAN CHASE & CO's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is JPMORGAN CHASE & CO a good investment in 2025?

Based on our AI analysis, JPMORGAN CHASE & CO shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are JPMORGAN CHASE & CO forecasts updated?

JPMORGAN CHASE & CO stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced JPMORGAN CHASE & CO Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for JPMORGAN CHASE & CO stock.

My Portfolio

Investment Dashboard

Loading your portfolio...